Cover Image
市場調查報告書

防止尿失禁用設備:開發平台分析

Incontinence Devices - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 344641
出版日期 內容資訊 英文 336 Pages
訂單完成後即時交付
價格
Back to Top
防止尿失禁用設備:開發平台分析 Incontinence Devices - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年09月12日 內容資訊: 英文 336 Pages
簡介

本報告提供全球各國的企業·醫療機關等正在開發的防止尿失禁用設備·用品之開發中產品資訊相關分析,提供您臨床實驗/產品開發的整體進展,及各階段·各領域·各地區的詳細趨勢,各企業·各產品的詳細資訊 (臨床實驗的進展階段,開始/結束時期,認證預測等),近來的產品開發的動向·產業趨勢等資料,為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 開發中的產品

  • 開發中產品:各開發階段
  • 開發中產品:各領域
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各認證時期 (估計)
  • 現在進行中的臨床實驗

第4章 防止尿失禁用設備:現在正在開發的開發中產品 (各企業)

  • 防止尿失禁用設備的開發企業:開發中產品 (各開發階段)
  • 防止尿失禁用設備:各開發階段的開發中產品一覽

第5章 防止尿失禁用設備的企業·產品概要

  • American Medical Systems Holdings, Inc.
    • 開發中產品及現在進行中的臨床實驗概要
  • Applied Catheter Technologies Inc.
  • AugmentRx Medical Inc.
  • Bioring SA (Inactive)
  • BioSurfaces, Inc.
  • Boston Scientific Corporation
  • Ceragenix Pharmaceuticals, Inc. (Inactive)
  • Compactcath, Inc.
  • Continara Limited (Inactive)
  • Continental Dry-Works
  • Covalon Technologies Ltd.
  • DUALIS MedTech GmbH
  • Elidah, LLC
  • EMKinetics, Inc.
  • Endo International Plc
  • EndoStim, Inc
  • Enox Biopharma, Inc
  • Ethicon, Inc.
  • Facet Technologies, LLC
  • FLEXIPROBE LTD.
  • Floelle Inc.
  • Forconti Medical Ltd.
  • Future Path Medical Holding, LLC
  • Generic Medical Devices, Inc.
  • GR Dome Medical Ltd.
  • GT Urological, LLC
  • Jabil, Inc.
  • Kleeven International BV
  • Leto Medical, LLC
  • Lilium Otsuka Co., Ltd.
  • Marvao Medical Devices Limited
  • Medici Medical Srl
  • Medi-Globe GmbH
  • Medisse BV
  • Medtronic plc
  • MyoPowers Medical Technologies SA
  • 長崎大學
  • NexHand
  • Olympus Corporation Medical Systems
  • PercuVision LLC
  • Precision Medical Devices, Inc.
  • Prosurg, Inc.
  • Proxy Biomedical Limited
  • Quick-Med Technologies, Inc.
  • Salusion B.V.
  • Sharklet Technologies, Inc.
  • Solace Therapeutics
  • Teleflex Incorporated
  • Tengion, Inc.
  • The Feinstein Institute for Medical Research
  • The University of Utah
  • TheraNova, LLC.
  • Universitat Politecnica de Catalunya
  • University of Basel
  • University of California, San Diego
  • University of Michigan Pediatric Device Consortium
  • University of Nottingham
  • Urinary BioSolutions LLC
  • Uromedica, Inc.
  • Urova Medical Inc.
  • Urovalve, Inc.
  • Verathon Inc.
  • Vesiflo, Inc.
  • Victhom Human Bionics Inc. (Inactive)
  • Vysera Biomedical Limited
  • Xennovate Medical LLC

第6章 防止尿失禁用設備:近來的市場趨勢

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0450EPD

GlobalData's Medical Devices sector report, "Incontinence Devices - Medical Devices Pipeline Assessment, 2017" provides an overview of Incontinence Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Incontinence Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Incontinence Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Incontinence Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • - Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • - Identify and understand important and diverse types of Incontinence Devices under development
  • - Develop market-entry and market expansion strategies
  • - Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • - In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 9
  • 1.2 List of Figures 14

2 Introduction 15

  • 2.1 Incontinence Devices Overview 15

3 Products under Development 16

  • 3.1 Incontinence Devices - Pipeline Products by Stage of Development 16
  • 3.2 Incontinence Devices - Pipeline Products by Segment 17
  • 3.3 Incontinence Devices - Pipeline Products by Territory 18
  • 3.4 Incontinence Devices - Pipeline Products by Regulatory Path 19
  • 3.5 Incontinence Devices - Pipeline Products by Estimated Approval Date 20
  • 3.6 Incontinence Devices - Ongoing Clinical Trials 21

4 Incontinence Devices - Pipeline Products under Development by Companies 22

  • 4.1 Incontinence Devices Companies - Pipeline Products by Stage of Development 22
  • 4.2 Incontinence Devices - Pipeline Products by Stage of Development 25

5 Incontinence Devices Companies and Product Overview 28

  • 5.1 Applied Catheter Technologies Inc. Company Overview 28
  • 5.2 Atlantic Therapeutics Group Ltd Company Overview 29
  • 5.3 AugmentRx Medical Inc. Company Overview 30
  • 5.4 Biocrede Inc Company Overview 31
  • 5.5 BioModics ApS Company Overview 32
  • 5.6 Bioring SA (Inactive) Company Overview 33
  • 5.7 Boston Scientific Corp Company Overview 34
  • 5.8 Ceragenix Pharmaceuticals, Inc. (Inactive) Company Overview 38
  • 5.9 Coloplast A/S Company Overview 39
  • 5.10 Continara Limited (Inactive) Company Overview 41
  • 5.11 Continental Dry-Works Company Overview 42
  • 5.12 Control Flo Medical LLC Company Overview 43
  • 5.13 ConvaTec Inc. Company Overview 44
  • 5.14 DUALIS MedTech GmbH Company Overview 45
  • 5.15 Ecole Polytechnique de Montreal Company Overview 46
  • 5.16 Elecro Chem, Inc. Company Overview 47
  • 5.17 Elidah, LLC Company Overview 48
  • 5.18 EMKinetics, Inc. Company Overview 49
  • 5.19 Endo International Plc Company Overview 50
  • 5.20 EndoStim Inc Company Overview 53
  • 5.21 Enox Biopharma Inc Company Overview 54
  • 5.22 Ergoresearch Ltd Company Overview 55
  • 5.23 Ethicon US LLC Company Overview 56
  • 5.24 Facet Technologies LLC Company Overview 57
  • 5.25 Flat Medical Company Overview 58
  • 5.26 FLEXIPROBE LTD. Company Overview 60
  • 5.27 Floelle Inc. Company Overview 61
  • 5.28 FocusStart LLC Company Overview 62
  • 5.29 Forconti Medical Ltd. Company Overview 63
  • 5.30 GR Dome Medical Ltd. Company Overview 66
  • 5.31 GT Urological, LLC Company Overview 68
  • 5.32 Hill-Rom Holdings Inc Company Overview 70
  • 5.33 Hollister Incorporated Company Overview 71
  • 5.34 Invent Medic Sweden AB Company Overview 72
  • 5.35 Kleeven International BV Company Overview 75
  • 5.36 Leto Medical, LLC Company Overview 76
  • 5.37 Lilium Otsuka Co., Ltd. Company Overview 77
  • 5.38 Marvao Medical Devices Limited Company Overview 78
  • 5.39 Medici Medical Srl Company Overview 79
  • 5.40 Medi-Globe GmbH Company Overview 80
  • 5.41 Medprin Regenerative Medical Technologies Co Ltd Company Overview 81
  • 5.42 Minnesota Medical Technologies Corporation Company Overview 82
  • 5.43 MyoPowers Medical Technologies France SAS Company Overview 83
  • 5.44 Nagasaki University Company Overview 84
  • 5.45 NexHand Company Overview 85
  • 5.46 Olympus Medical Systems Corp Company Overview 86
  • 5.47 PetVivo Holdings Inc Company Overview 87
  • 5.48 Polytechnic University of Catalonia Company Overview 88
  • 5.49 Precision Medical Devices, Inc. Company Overview 89
  • 5.50 Prosurg Inc Company Overview 91
  • 5.51 Proxy Biomedical Ltd Company Overview 92
  • 5.52 Quick-Med Technologies, Inc. Company Overview 93
  • 5.53 Rambam Health Care Campus Company Overview 94
  • 5.54 Salusion B.V. Company Overview 95
  • 5.55 Sharklet Technologies, Inc. Company Overview 96
  • 5.56 Solace Therapeutics Inc Company Overview 97
  • 5.57 Stanford University Company Overview 100
  • 5.58 Suneva Medical Inc Company Overview 101
  • 5.59 Tengion Inc Company Overview 102
  • 5.60 The Feinstein Institute for Medical Research Company Overview 103
  • 5.61 University of Basel Company Overview 105
  • 5.62 University of California San Diego Company Overview 106
  • 5.63 University of Michigan Pediatric Device Consortium Company Overview 107
  • 5.64 University of Nottingham Company Overview 108
  • 5.65 University of Saskatchewan Company Overview 109
  • 5.66 University of Utah Company Overview 110
  • 5.67 Urinary BioSolutions LLC (Inactive) Company Overview 112
  • 5.68 Uromedica Inc Company Overview 113
  • 5.69 UroMems SAS Company Overview 116
  • 5.70 Urova Medical Inc. Company Overview 117
  • 5.71 Urovalve, Inc. Company Overview 118
  • 5.72 Verathon Inc Company Overview 120
  • 5.73 Vesiflo, Inc. Company Overview 123
  • 5.74 Vysera Biomedical Ltd Company Overview 124
  • 5.75 Washington University in St Louis Company Overview 125
  • 5.76 Watkins Conti Products Inc Company Overview 126
  • 5.77 Xennovate Medical LLC Company Overview 129

6 Incontinence Devices- Recent Developments 131

  • 6.1 Aug 31, 2017: The Cooper Companies Announces Third Quarter 2017 Results 131
  • 6.2 Aug 30, 2017: Medline Remains Operational Through Hurricane Harvey and Current Recovery 131
  • 6.3 Aug 29, 2017: Gilles Laporte elected on the Board of Directors of Ergoresearch 132
  • 6.4 Aug 28, 2017: Bactiguard Appoints New CFO 132
  • 6.5 Aug 23, 2017: Henry Ford Hospital CEO Announces Retirement 133
  • 6.6 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 133
  • 6.7 Aug 21, 2017: Covalon Releases Third Quarter Financial Results 136
  • 6.8 Aug 16, 2017: Kane Biotech - Q2 2017 Financial Results 137
  • 6.9 Aug 16, 2017: Coloplast delivers satisfactory Q3 result 137
  • 6.10 Aug 14, 2017: ConvaTec appoints two Non-Executive Directors 138
  • 6.11 Aug 14, 2017: Zynex Announces 2017 Second Quarter Earnings 139
  • 6.12 Aug 10, 2017: Bactiguard Holding: Interim report for Q2 2017 140
  • 6.13 Aug 10, 2017: Invo Bioscience Reports Record Second Quarter 2017 Financial Results 142
  • 6.14 Aug 09, 2017: HARTMANN GROUP is investing in the future 143
  • 6.15 Aug 09, 2017: Dentsply Sirona Reports Second Quarter 2017 Results 144
  • 6.16 Aug 09, 2017: Sientra Reports Second Quarter 2017 Financial Results 146
  • 6.17 Aug 08, 2017: Endo Reports Second-Quarter 2017 Financial Results 147
  • 6.18 Aug 03, 2017: ConvaTec Group: Board Changes 149
  • 6.19 Aug 03, 2017: ConvaTec Group First Half 2017 Results 150
  • 6.20 Aug 03, 2017: Teleflex Reports Second Quarter 2017 Results 151
  • 6.21 Aug 01, 2017: Owens & Minor Reports 2nd Quarter 2017 Financial Results 153
  • 6.22 Jul 31, 2017: Sanofi Raises FY 2017 Business EPS Guidance to Broadly Stable at CER 154
  • 6.23 Jul 31, 2017: Dr. Joachim Schulz joins the Management Board of B. Braun Melsungen 161
  • 6.24 Jul 28, 2017: Indonesian Minister of Health Launches New German Pharmaceutical Factory in Karawang 162
  • 6.25 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 162
  • 6.26 Jul 21, 2017: Endo to Restructure Manufacturing Network 164
  • 6.27 Jul 20, 2017: Atlantic Therapeutics Announce Partnership with Female Pelvic Health Specialists June Medical 165
  • 6.28 Jul 19, 2017: Merz To Consolidate Operations in Racine County, Create Up To 20 Jobs 165
  • 6.29 Jul 12, 2017: Sanofi: Pre-quarterly Results Communication 165
  • 6.30 Jul 11, 2017: Uromedica Announces Launch of ProACT Adjustable Continence Therapy for Men with FDA Approval and Reimbursement Coding 167
  • 6.31 Jul 08, 2017: Class Action Regarding Boston Scientific Transvaginal Mesh Devices Has Been Certified 168

7 Appendix 332

  • 7.1 Methodology 332
  • 7.2 About GlobalData 335
  • 7.3 Contact Us 335
  • 7.4 Disclaimer 335

List of Tables

1.1 List of Tables

  • Table 1: Incontinence Devices - Pipeline Products by Stage of Development 17
  • Table 2: Incontinence Devices - Pipeline Products by Segment 18
  • Table 3: Incontinence Devices - Pipeline Products by Territory 19
  • Table 4: Incontinence Devices - Pipeline Products by Regulatory Path 20
  • Table 5: Incontinence Devices - Pipeline Products by Estimated Approval Date 21
  • Table 6: Incontinence Devices - Ongoing Clinical Trials 22
  • Table 7: Incontinence Devices Companies - Pipeline Products by Stage of Development 23
  • Table 8: Incontinence Devices - Pipeline Products by Stage of Development 26
  • Table 9: Applied Catheter Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 10: Drug Coated Catheter - Product Status 29
  • Table 11: Drug Coated Catheter - Product Description 29
  • Table 12: Atlantic Therapeutics Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 13: INNOVO - Product Status 30
  • Table 14: INNOVO - Product Description 30
  • Table 15: AugmentRx Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 16: SOLVE - Product Status 31
  • Table 17: SOLVE - Product Description 31
  • Table 18: Biocrede Inc Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 19: Urinary Catheter - Product Status 32
  • Table 20: Urinary Catheter - Product Description 32
  • Table 21: BioModics ApS Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 22: Indwelling Urinary Catheter - Product Status 33
  • Table 23: Indwelling Urinary Catheter - Product Description 33
  • Table 24: Bioring SA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 25: Biowing - Product Status 34
  • Table 26: Biowing - Product Description 34
  • Table 27: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 28: Next Generation Sling System - Product Status 35
  • Table 29: Next Generation Sling System - Product Description 35
  • Table 30: Pathfinder RP - Product Status 36
  • Table 31: Pathfinder RP - Product Description 36
  • Table 32: Pathfinder TOT - Product Status 36
  • Table 33: Pathfinder TOT - Product Description 37
  • Table 34: SIS Sling System - Product Status 37
  • Table 35: SIS Sling System - Product Description 37
  • Table 36: Solyx I Sling System - Product Status 38
  • Table 37: Solyx I Sling System - Product Description 38
  • Table 38: Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 39
  • Table 39: Cerashield Coated Silicone Urinary Catheter - Product Status 39
  • Table 40: Cerashield Coated Silicone Urinary Catheter - Product Description 39
  • Table 41: Coloplast A/S Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 42: SpeediCath Compact Eve CH10 - Product Status 40
  • Table 43: SpeediCath Compact Eve CH10 - Product Description 40
  • Table 44: SpeediCath Compact Eve CH14 - Product Status 41
  • Table 45: SpeediCath Compact Eve CH14 - Product Description 41
  • Table 46: Continara Limited (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 47: UTROL Bionic Sphincter - Product Status 42
  • Table 48: UTROL Bionic Sphincter - Product Description 42
  • Table 49: Continental Dry-Works Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 50: The Pocket - Product Status 43
  • Table 51: The Pocket - Product Description 43
  • Table 52: Control Flo Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 53: ResQ Urological Catheter System - Product Status 44
  • Table 54: ResQ Urological Catheter System - Product Description 44
  • Table 55: ConvaTec Inc. Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 56: GentleCath Glide Intermittent Catheter - Product Status 45
  • Table 57: GentleCath Glide Intermittent Catheter - Product Description 45
  • Table 58: DUALIS MedTech GmbH Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 59: Implantable Wireless Sphincter System - Product Status 46
  • Table 60: Implantable Wireless Sphincter System - Product Description 46
  • Table 61: Ecole Polytechnique de Montreal Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 62: Bladder Implant - Product Status 47
  • Table 63: Bladder Implant - Product Description 47
  • Table 64: Elecro Chem, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
  • Table 65: TVS 2 - Product Status 48
  • Table 66: TVS 2 - Product Description 48
  • Table 67: Elidah, LLC Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 68: Elitone - Product Status 49
  • Table 69: Elitone - Product Description 49
  • Table 70: EMKinetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 71: TranStim Transdermal Neuromodulation System - Product Status 50
  • Table 72: TranStim Transdermal Neuromodulation System - Product Description 50
  • Table 73: Endo International Plc Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 74: CONTINUUM Device - Product Status 51
  • Table 75: CONTINUUM Device - Product Description 51
  • Table 76: TOPAS Sling System - Product Status 52
  • Table 77: TOPAS Sling System - Product Description 52
  • Table 78: UroVive Self-Contained Micro-Balloon System - Product Status 52
  • Table 79: UroVive Self-Contained Micro-Balloon System - Product Description 53
  • Table 80: EndoStim Inc Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 81: Implantable Device - Urinary Incontinence - Product Status 54
  • Table 82: Implantable Device - Urinary Incontinence - Product Description 54
  • Table 83: Enox Biopharma Inc Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 84: Self-Sterilizing Urinary Catheter - Product Status 55
  • Table 85: Self-Sterilizing Urinary Catheter - Product Description 55
  • Table 86: Ergoresearch Ltd Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 87: Urinary Disorders Implant - Product Status 56
  • Table 88: Urinary Disorders Implant - Product Description 56
  • Table 89: Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 90: GYNECARE SUI Sling Next Generation - Product Status 57
  • Table 91: GYNECARE SUI Sling Next Generation - Product Description 57
  • Table 92: Facet Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 58
  • Table 93: Periurethral Device - Product Status 58
  • Table 94: Periurethral Device - Product Description 58
  • Table 95: Flat Medical Pipeline Products & Ongoing Clinical Trials Overview 59
  • Table 96: UroAid - F - Product Status 59
  • Table 97: UroAid - F - Product Description 59
  • Table 98: UroAid - IV - Product Status 60
  • Table 99: UroAid - IV - Product Description 60
  • Table 100: FLEXIPROBE LTD. Pipeline Products & Ongoing Clinical Trials Overview 61
  • Table 101: Flexiprobe Device - Product Status 61
  • Table 102: Flexiprobe Device - Product Description 61
  • Table 103: Floelle Inc. Pipeline Products & Ongoing Clinical Trials Overview 62
  • Table 104: Floelle Device - Product Status 62
  • Table 105: Floelle Device - Product Description 62
  • Table 106: FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 63
  • Table 107: Anti-biofilm Urological Catheter - Product Status 63
  • Table 108: Anti-biofilm Urological Catheter - Product Description 63
  • Table 109: Forconti Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 64
  • Table 110: ForConti Fecal Management System - Product Status 64
  • Table 111: ForConti Fecal Management System - Product Description 64
  • Table 112: Forconti Medical Ltd. - Ongoing Clinical Trials Overview 65
  • Table 113: ForConti Fecal Management System - Safety and Effectiveness Evaluation of the ForConti Fecal Management System - Pilot Study 66
  • Table 114: GR Dome Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 67
  • Table 115: UriCap-F - Product Status 67
  • Table 116: UriCap-F - Product Description 67
  • Table 117: UriTop-F - Product Status 68
  • Table 118: UriTop-F - Product Description 68
  • Table 119: GT Urological, LLC Pipeline Products & Ongoing Clinical Trials Overview 69
  • Table 120: Fecal Incontinence Device - Product Status 69
  • Table 121: Fecal Incontinence Device - Product Description 69
  • Table 122: Implantable Incontinence Device - Women - Product Status 70
  • Table 123: Implantable Incontinence Device - Women - Product Description 70
  • Table 124: Hill-Rom Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 71
  • Table 125: WatchCare Incontinence Management Device - Product Status 71
  • Table 126: WatchCare Incontinence Management Device - Product Description 71
  • Table 127: Hollister Incorporated Pipeline Products & Ongoing Clinical Trials Overview 72
  • Table 128: VaPro Touch Free Male Hydrophilic Intermittent Catheter - Product Status 72
  • Table 129: VaPro Touch Free Male Hydrophilic Intermittent Catheter - Product Description 72
  • Table 130: Invent Medic Sweden AB Pipeline Products & Ongoing Clinical Trials Overview 73
  • Table 131: TVS - Product Status 73
  • Table 132: TVS - Product Description 73
  • Table 133: Invent Medic Sweden AB - Ongoing Clinical Trials Overview 74
  • Table 134: TVS - An Open Randomized Controlled Multicenter Clinical Investigation with an Intra-vaginal Device for Stress Urinary Incontinence in Comparison to using Standard of Care 75
  • Table 135: Kleeven International BV Pipeline Products & Ongoing Clinical Trials Overview 76
  • Table 136: MAXAM Pelvic Floor Device - Product Status 76
  • Table 137: MAXAM Pelvic Floor Device - Product Description 76
  • Table 138: Leto Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 77
  • Table 139: Continent Ostomy System - Product Status 77
  • Table 140: Continent Ostomy System - Product Description 77
  • Table 141: Lilium Otsuka Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 78
  • Table 142: Next Gen Yuririn USH-052 Scanner - Product Status 78
  • Table 143: Next Gen Yuririn USH-052 Scanner - Product Description 78
  • Table 144: Marvao Medical Devices Limited Pipeline Products & Ongoing Clinical Trials Overview 79
  • Table 145: NexSite Drainage Catheter - Product Status 79
  • Table 146: NexSite Drainage Catheter - Product Description 79
  • Table 147: Medici Medical Srl Pipeline Products & Ongoing Clinical Trials Overview 80
  • Table 148: Time-Delayed Valve System - Product Status 80
  • Table 149: Time-Delayed Valve System - Product Description 80
  • Table 150: Medi-Globe GmbH Pipeline Products & Ongoing Clinical Trials Overview 81
  • Table 151: Incontinence Prosthesis - Product Status 81
  • Table 152: Incontinence Prosthesis - Product Description 81
  • Table 153: Medprin Regenerative Medical Technologies Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 82
  • Table 154: Regen Sling - Product Status 82
  • Table 155: Regen Sling - Product Description 82
  • Table 156: Minnesota Medical Technologies Corporation Pipeline Products & Ongoing Clinical Trials Overview 83
  • Table 157: myMiracle - Product Status 83
  • Table 158: myMiracle - Product Description 83
  • Table 159: MyoPowers Medical Technologies France SAS Pipeline Products & Ongoing Clinical Trials Overview 84
  • Table 160: ARTUS - Product Status 84
  • Table 161: ARTUS - Product Description 84
  • Table 162: Nagasaki University Pipeline Products & Ongoing Clinical Trials Overview 85
  • Table 163: Urination Management System - Product Status 85
  • Table 164: Urination Management System - Product Description 85

List of Figures

1.2 List of Figures

  • Figure 1: Incontinence Devices - Pipeline Products by Stage of Development 17
  • Figure 2: Incontinence Devices - Pipeline Products by Segment 18
  • Figure 3: Incontinence Devices - Pipeline Products by Territory 19
  • Figure 4: Incontinence Devices - Pipeline Products by Regulatory Path 20
  • Figure 5: Incontinence Devices - Pipeline Products by Estimated Approval Date 21
  • Figure 6: Incontinence Devices - Ongoing Clinical Trials 22
Back to Top